Periodontitis and diabetes associations with measures of atherosclerosis and CHD

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 196-201

  Southerland, Janet H ^a   Moss, Kevin ^b   Taylor, George W ^c   Beck, James D ^b   Pankow, James ^d   Gangula, Pandu R ^a   Offenbacher, Steven ^e  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Acoustic shadowing; Coronary heart disease; Inflammatory mediators; Intimal medial wall thickness; Metabolic control; Periodontal disease

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACOUSTIC SHADOWING; ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMA; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CALCIFICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCOME; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIODONTAL DISEASE; PERIODONTITIS; PREVALENCE; PRIORITY JOURNAL; RACE; SMOKING; STAINING; TOOTH; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODONTITIS; RISK; UNITED STATES;

EID: 84859875695     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.026     Document Type: Article

References (48)

1. Mattila K.J., Asikainen S., Wolf J., et al. Age, dental infections, and coronary heart disease. J Dent Res 2000, 79(2):756-760.
2. Schmidt M.I., Duncan B.B., Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999, 353(9165):1649-1652.
3. Rittie L., Berton A., Monboisse J.C., Hornebeck W., Gillery P. Decreased contraction of glycated collagen lattices coincides with impaired matrix metalloproteinase production. Biochem Biophys Res Commun 1999, 264(2):488-492.
4. Taylor G.W., Borgnakke W.S. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis 2008, (3):204-205.
5. Taylor G.W. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 2001, 6:99-112.
6. Tsai C., Hayes C., Taylor G.W. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002, 30(3):182-192.
7. Abou-Raya S., Naeem A., Abou-El K.H., El B.S. Coronary artery disease and periodontal disease: is there a link?. Angiology 2002, 53(2):141-148.
8. Reaven G.M. Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia. Diabetes Obes Metab 2002, 4(Suppl. 1):S13-S18.
9. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991, 87(2):432-438.
10. Hogan M., Cerami A., Bucala R. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 1992, 90(3):1110-1115.
11. Virella G., Thorp S.R., Alderson N.L., et al. Autoimmune response to advanced glycosylation end-products of human LDL. J Lipid Res 2003, 44(3):487-493.
12. Sobal G., Menzel J., Sinzinger H. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids 2000, 63(4):177-186.
13. Steinberg D., Carew T.E., Fielding C., et al. Lipoproteins and the pathogenesis of atherosclerosis. Circulation 1989, 80(3):719-723.
14. Mattila K.J., Valle M.S., Nieminen M.S., Valtonen V.V., Hietaniemi K.L. Dental infections and coronary atherosclerosis. Atherosclerosis 1993, 103(2):205-211.
15. Genco R., Offenbacher S., Beck J. Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent Assoc 2002, 133(Suppl.):14S-22S.
16. Beck J.D., Slade G., Offenbacher S. Oral disease, cardiovascular disease and systemic inflammation. Periodontol 2000 2000, 23:110-120.
17. Mattila K.J., Valtonen V.V., Nieminen M., Huttunen J.K. Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995, 20(3):588-592.
18. Beck J.D., Elter J.R., Heiss G., et al. Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001, 21(11):1816-1822.
19. Beck J.D., Eke P., Lin D., et al. Associations between IgG antibody of oral organism and carotid intima-media thickness in community-dwelling adults. Atherosclerosis 2005, 183:342-348.
20. Feingold K.R., Soued M., Serio M.K., et al. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 1989, 125(1):267-274.
21. Jackson R., Chambless L.E., Yang K., et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol 1996, 49(12):1441-1446.
22. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986, 74(6):1399-1406.
23. O' Leary D., Polak J., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
24. Chambless L., Folsom A., Clegg L., et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities Study. AJE 2000, 151:478-487.
25. Bond M.G., Purvis C., Mercuri M. Antiatherogenic properties of calcium antagonists. J Cardiovasc Pharmacol 1991, 17(Suppl. 4):S87-S92. discussion S92-3.
26. DeStefano F., Anda R.F., Kahn H.S., Williamson D.F., Russell C.M. Dental disease and risk of coronary heart disease and mortality. BMJ 1993, 306(6879):688-691.
27. Wagenknecht L.E., D'Agostino R., Savage P.J., et al. Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997, 28(5):999-1005.
28. Mealey B.L., Rethman M.P. Periodontal disease and diabetes mellitus. Bidirectional relationship. Dent Today 2003, 22(4):107-113.
29. Almas K., Al-Qahtani M., Al-Yami M., Khan N. The relationship between periodontal disease and blood glucose level among type II diabetic patients. J Contemp Dent Pract 2001, 2(4):18-25.
30. Nishimura F., Murayama Y. Periodontal inflammation and insulin resistance-lessons from obesity. J Dent Res 2001, 80(8):1690-1694.
31. Janket S.J., Baird A.E., Chuang S.K., Jones J.A. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 95(5):559-569.
32. Katz J., Marc H., Porter S., Ruskin J. Inflammation, periodontitis, and coronary heart disease. Lancet 2001, 358(9297):1998.
33. Lalla E., Lamster I.B., Drury S., Fu C., Schmidt A.M. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontol 2000 2000, 23(1):50-62.
34. Offenbacher S. Commentary: clinical implications of periodontal disease assessments using probing depth and bleeding on probing to measure the status of the periodontal-biofilm interface. J Int Acad Periodontol 2005, (7):157-161.
35. Beck J.D., Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol 2002, (7):79-89.
36. Offenbacher S., Barros S.P., Beck J.D. Rethinking periodontal inflammation. J Periodontol 2008, 79:1577-1584.
37. Page R.C., Eke P. Case definitions for USE in population-base surveillance of periodontitis. J Periodontol 2007, 78:1387-1399.
38. American Academy of Periodontology Diagnosis of periodontol diseases (position paper). J Periodontol 2003, 74:1237-1247.
39. Greenstein G. Contemporary interpretation of probing depth assessments: diagnostic and therapeutic indications. A literature review. J Periodontol 1997, 68:1194-1205.
40. Beck J.D. Attachment loss trends in community dwelling older blacks and whites over 3 years. J Dent Res 1992, 72:p264.
41. Elter J.R., Hinderliter A.L., Offenbacher S., et al. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 2006, 151(1):47.
42. Tonetti M.S., D'Aiuto F., Nibali L., et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007, 356(9):911-920.
43. Saremi A., Nelson R.G., Tulloch-Reid M., et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005, 28:27-32.
44. Andriankaja O.M., Sreenivasa S., Dunford R., DeNardin E. Association between metabolic syndrome and periodontal disease. Aust Dent J 2010, 55:252-259.
45. Lapu-Bula R., Ofili E. From hypertension to heart failure: role of nitric oxide-mediated endothelial dysfunction and emerging insights from myocardial contrast echocardiography. Am J Cardiol 2007, 99:7D-14D.
46. Hajjar I., Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003, 290:199-206.
47. Eugenia M.-G., Chen D.-B. Racial differences in nitric oxide-mediated vasorelaxation. Reprod Sci 2008, 15:9-25.
48. Higashi Y., Goto C., Hidaka T., et al. Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease. Atherosclerosis 2009, 206:604-610.